Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries

Current Opinion in Chemical Biology

Volumn 9, Issue 3, 2005, Pages 248-258

  Shang, Shiying ^a   Tan, Derek S ^a,b  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXANE DERIVATIVE; ANTIINFECTIVE AGENT; BENZOPYRAN DERIVATIVE; CHOLINESTERASE INHIBITOR; DYSIDIOLIDE; FEXACHLORAMIDE; GALANTAMINE; GELATINASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; MEPYRAMINE MALEATE; NATURAL PRODUCT; PROTEIN INHIBITOR; RECEPTOR BLOCKING AGENT; SECRAMINE; SPIROTRYPROSTATIN B; STILBENE DERIVATIVE; TSRI 265; TUBACIN; UNCLASSIFIED DRUG; UREPTUPAMINE B; VANCOMYCIN;

BIOLOGY; CHEMISTRY; DATA BASE; DRUG DESIGN; DRUG STRUCTURE; MOLECULAR LIBRARY; NONHUMAN; ORGANIC CHEMISTRY; REVIEW; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

BIOLOGICAL FACTORS; COMBINATORIAL CHEMISTRY TECHNIQUES; DATABASES, PROTEIN; DRUG DESIGN; MOLECULAR STRUCTURE; PROTEIN CONFORMATION;

EID: 20444410443     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2005.03.006     Document Type: Review

References (74)

1. M.D. Lee, Y. She, M.J. Soskis, C.P. Borella, J.R. Gardner, P.A. Hayes, B.M. Dy, M.L. Heaney, M.R. Philips, W.G. Bornmann, F.M. Sirotnak, and D.A. Scheinberg Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics J Clin Invest 114 2004 1107 1116
2. R. Bagatell, and L. Whitesell Altered Hsp90 function in cancer: a unique therapeutic opportunity Mol Cancer Ther 3 2004 1021 1030
3. C.L. Sawyers Will mTOR inhibitors make it as cancer drugs? Cancer Cell 4 2003 343 348
4. R.W. Johnstone Histone-deacetylase inhibitors: novel drugs for the treatment of cancer Nat Rev Drug Discov 1 2002 287 299
5. R. Kerbel, and J. Folkman Clinical translation of angiogenesis inhibitors Nat Rev Cancer 2 2002 727 739
6. J. Mann Natural products in cancer chemotherapy: past, present and future Nat Rev Cancer 2 2002 143 148
7. C.M. Dobson Chemical space and biology Nature 432 2004 824 828 A recent discussion of chemical space and its intersections with biology.
8. M.S. Lajiness, M. Vieth, and J. Erickson Molecular properties that influence oral drug-like behavior Curr Opin Drug Discov Devel 7 2004 470 477 An excellent recent review of approaches to delineating drug-like properties and caveats in applying them.
9. L. Di, and E.H. Kerns Profiling drug-like properties in discovery research Curr Opin Chem Biol 7 2003 402 408
10. A.M. Rouhi Rediscovering natural products Chem Eng News 81 2003 77 91
11. D.J. Newman, G.M. Cragg, and K.M. Snader Natural products as sources of new drugs over the period 1981-2002 J Nat Prod 66 2003 1022 1037
12. M. Feher, and J.M. Schmidt Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry J Chem Inf Comput Sci 43 2003 218 227
13. C. Lipinski, and A. Hopkins Navigating chemical space for biology and medicine Nature 432 2004 855 861
14. A.M. Rouhi Betting on natural products for cues Chem Eng News 81 2003 93 103
15. J. Clardy, and C. Walsh Lessons from natural molecules Nature 432 2004 829 837
16. D.S. Tan Current progress in natural product-like libraries for discovery screening Comb Chem High Throughput Screen 7 2004 631 643 A thorough review on current progress in DOS of natural product-like libraries for discovery screening with additional examples of biological probes identified from these libraries.
17. P.A. Tempest, and R.W. Armstrong Cyclobutenedione derivatives on solid support: Toward multiple core structure libraries J Am Chem Soc 119 1997 7607 7608
18. M.A. Marx, A-L. Grillot, C.T. Louer, K.A. Beaver, and P.A. Bartlett Synthetic design for combinatorial chemistry. Solution and polymer-supported synthesis of polycyclic lactams by intramolecular cyclization of azomethine ylides J Am Chem Soc 119 1997 6153 6167
19. D.S. Tan, M.A. Foley, M.D. Shair, and S.L. Schreiber Stereoselective synthesis of over two million compounds having structural features both reminiscent of natural products and compatible with miniaturized cell-based assays J Am Chem Soc 120 1998 8565 8566
20. D.S. Tan, M.A. Foley, B.R. Stockwell, M.D. Shair, and S.L. Schreiber Synthesis and preliminary evaluation of a library of polycyclic small molecules for use in chemical genetic assays J Am Chem Soc 121 1999 9073 9087
21. D.G. Hall, S. Manku, and F. Wang Solution- and solid-phase strategies for the design, synthesis, and screening of libraries based on natural product templates: a comprehensive survey J Comb Chem 3 2001 125 150
22. R. Breinbauer, I.R. Vetter, and H. Waldmann From protein domains to drug candidates: Natural products as guiding principles in the design and synthesis of compound libraries Angew Chem Int Ed Engl 41 2002 2879 2890
23. B.E. Evans, K.E. Rittle, M.G. Bock, R.M. DiPardo, R.M. Freidinger, W.L. Whitter, G.F. Lundell, D.F. Veber, P.S. Anderson, and RS.L. Chang Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists J Med Chem 31 1988 2235 2246
24. H.E. Pelish, N.J. Westwood, Y. Feng, T. Kirchhausen, and M.D. Shair Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product J Am Chem Soc 123 2001 6740 6741
25. P. Stahl, L. Kissau, R. Mazitschek, A. Giannis, and H. Waldmann Natural product derived receptor tyrosine kinase inhibitors: identification of IGF1R, Tie-2, and VEGFR-3 inhibitors Angew Chem Int Ed Engl 41 2002 1174 1178
26. L. Kissau, P. Stahl, R. Mazitschek, A. Giannis, and H. Waldmann Development of natural product-derived receptor tyrosine kinase inhibitors based on conservation of protein domain fold J Med Chem 46 2003 2917 2931
27. M.A. Koch, L.-O. Wittenberg, S. Basu, D.A. Jeyaraj, E. Gourzoulidou, K. Reinecke, A. Odermatt, and H. Waldmann Compound library development guided by protein structure similarity clustering and natural product structure Proc Natl Acad Sci USA 101 2004 16721 16726 In this study, individual protein domains were grouped into a protein structure similarity cluster. Analogs of a natural product that bound one member of this cluster were used to develop selective ligands for other members.
28. M.M.C. Lo, C.S. Neumann, S. Nagayama, E.O. Perlstein, and S.L. Schreiber A library of spirooxindoles based on a stereoselective three-component coupling reaction J Am Chem Soc 126 2004 16077 16086
29. M.-L. Lee, and G. Schneider Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries J Comb Chem 3 2001 284 289
30. K.C. Nicolaou, J.A. Pfefferkorn, A.J. Roecker, G.Q. Cao, S. Barluenga, and H.J. Mitchell Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans J Am Chem Soc 122 2000 9939 9953
31. K.C. Nicolaou, J.A. Pfefferkorn, H.J. Mitchell, A.J. Roecker, S. Barluenga, G.Q. Cao, R.L. Affleck, and J.E. Lillig Natural product-like combinatorial libraries based on privileged structures. 2. Construction of a 10 000-membered benzopyran library by directed split-and-pool chemistry using NanoKans and optical encoding J Am Chem Soc 122 2000 9954 9967
32. K.C. Nicolaou, J.A. Pfefferkorn, S. Barluenga, H.J. Mitchell, A.J. Roecker, and G.Q. Cao Natural product-like combinatorial libraries based on privileged structures. 3. The "libraries from libraries" principle for diversity enhancement of benzopyran libraries J Am Chem Soc 122 2000 9968 9976
33. K.C. Nicolaou, J.A. Pfefferkorn, F. Schuler, A.J. Roecker, G.Q. Cao, and J.E. Casida Combinatorial synthesis of novel and potent inhibitors of NADH:ubiquinone oxidoreductase Chem Biol 7 2000 979 992
34. K.C. Nicolaou, A.J. Roecker, S. Barluenga, J.A. Pfefferkorn, and G.Q. Cao Discovery of novel antibacterial agents active against methicillin-resistant Staphylococcus aureus from combinatorial benzopyran libraries ChemBioChem 2 2001 460 465
35. K.C. Nicolaou, R.M. Evans, A.J. Roecker, R. Hughes, M. Downes, and J.A. Pfefferkorn Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries Org Biomol Chem 1 2003 908 920
36. D. Lee, J.K. Sello, and S.L. Schreiber A strategy for macrocyclic ring closure and functionalization aimed toward split-pool syntheses J Am Chem Soc 121 1999 10648 10649
37. Q. Su, A.B. Beeler, E. Lobkovsky, J.A. Porco, and J.S. Panek Stereochemical diversity through cyclodimerization: Synthesis of polyketide-like macrodiolides Org Lett 5 2003 2149 2152
38. D.R. Schmidt, O. Kwon, and S.L. Schreiber Macrolactones in diversity-oriented synthesis: Preparation of a pilot library and exploration of factors controlling macrocyclization J Comb Chem 6 2004 286 292
39. Y.-k. Kim, M.A. Arai, T. Arai, J.O. Lamenzo, E.F. Dean III, N. Patterson, P.A. Clemons, and S.L. Schreiber Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space J Am Chem Soc 126 2004 14740 14745 This intriguing study quantitatively analyzes the influences of macrocyclization and stereochemistry upon biological specificity and global activity trends.
40. S.M. Sternson, J.B. Louca, J.C. Wong, and S.L. Schreiber Split-pool synthesis of 1,3-dioxanes leading to arrayed stock solutions of single compounds sufficient for multiple phenotypic and protein-binding assays J Am Chem Soc 123 2001 1740 1747
41. J.C. Wong, S.M. Sternson, J.B. Louca, R. Hong, and S.L. Schreiber Modular synthesis and preliminary biological evaluation of stereochemically diverse 1,3-dioxanes Chem Biol 11 2004 1279 1291
42. F.G. Kuruvilla, A.F. Shamji, S.M. Sternson, P.J. Hergenrother, and S.L. Schreiber Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays Nature 416 2002 653 657 A key demonstration of the use of a natural product-like library to identify a novel function-selective inhibitor of a nutrient-responsive signaling protein.
43. S.J. Haggarty, K.M. Koeller, J.C. Wong, C.M. Grozinger, and S.L. Schreiber Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation Proc Natl Acad Sci USA 100 2003 4389 4394
44. J.C. Wong, R. Hong, and S.L. Schreiber Structural biasing elements for in-cell histone deacetylase paralog selectivity J Am Chem Soc 125 2003 5586 5587
45. S.J. Haggarty, K.M. Koeller, J.C. Wong, R.A. Butcher, and S.L. Schreiber Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays Chem Biol 10 2003 383 396
46. D.L. Boger, J. Desharnais, and K. Capps Solution-phase combinatorial libraries: modulating cellular signaling by targeting protein-protein or protein-DNA interactions Angew Chem Int Ed Engl 42 2003 4138 4176
47. D.L. Boger Solution-phase synthesis of combinatorial libraries designed to modulate protein-protein or protein-DNA interactions Bioorg Med Chem 11 2003 1607 1613
48. L. Pagliaro, J. Felding, K. Audouze, S.J. Nielsen, R.B. Terry, C. Krog-Jensen, and S. Butcher Emerging classes of protein-protein interaction inhibitors and new tools for their development Curr Opin Chem Biol 8 2004 442 449
49. 3 J Am Chem Soc 123 2001 1280 1288
50. J. Goldberg, Q. Jin, Y. Ambroise, S. Satoh, J. Desharnais, K. Capps, and D.L. Boger Erythropoietin mimetics derived from solution phase combinatorial libraries J Am Chem Soc 124 2002 544 555
51. D.L. Boger, J. Goldberg, S. Satoh, Y. Ambroise, S.B. Cohen, and P.K. Vogt Non-amide-based combinatorial libraries derived from N-BOC-iminodiacetic acid: solution-phase synthesis of piperazinone libraries with activity against LEF-1/β-catenin-mediated transcription Helv Chim Acta 83 2000 1825 1845
52. D.L. Boger, J.K. Lee, J. Goldberg, and Q. Jin Two comparisons of the performance of positional scanning and deletion synthesis for the identification of active constituents in mixture combinatorial libraries J Org Chem 65 2000 1467 1474
53. T. Berg, S.B. Cohen, J. Desharnais, C. Sonderegger, D.J. Maslyar, J. Goldberg, D.L. Boger, and P.K. Vogt Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts Proc Natl Acad Sci USA 99 2002 3830 3835
54. D.L. Boger, B.E. Fink, and M.P. Hedrick Total synthesis of distamycin A and 2640 analogs: A solution-phase combinatorial approach to the discovery of new, bioactive DNA binding agents and development of a rapid, high-throughput screen for determining relative DNA binding affinity or DNA binding sequence selectivity J Am Chem Soc 122 2000 6382 6394
55. S.J. Taylor, A.M. Taylor, and S.L. Schreiber Synthetic strategy toward skeletal diversity via solid-supported, otherwise unstable reactive intermediates Angew Chem Int Ed Engl 43 2004 1681 1685
56. M.D. Burke, E.M. Berger, and S.L. Schreiber Generating diverse skeletons of small molecules combinatorially Science 302 2003 613 618 This report demonstrates conversion of a collection of substrates with pre-encoded skeletal information into products having distinct skeletons using a common set of reaction conditions.
57. M.D. Burke, E.M. Berger, and S.L. Schreiber A synthesis strategy yielding skeletally diverse small molecules combinatorially J Am Chem Soc 126 2004 14095 14104
58. M.D. Burke, and S.L. Schreiber A planning strategy for diversity-oriented synthesis Angew Chem Int Ed Engl 43 2004 46 58
59. H. Oguri, and S.L. Schreiber Skeletal diversity via a folding pathway: synthesis of indole alkaloid-like skeletons Org Lett 7 2005 47 50
60. L. Weber High-diversity combinatorial libraries Curr Opin Chem Biol 4 2000 295 302 A review on strategies in synthetic chemistry that enable the creation of natural product-like libraries.
61. C. Chen, X. Li, and S.L. Schreiber Catalytic asymmetric [3+2] cycloaddition of azomethine ylides. Development of a versatile stepwise, three-component reaction for diversity-oriented synthesis J Am Chem Soc 125 2003 10174 10175
62. P.R. Andreana, C.C. Liu, and S.L. Schreiber Stereochemical control of the Passerini reaction Org Lett 6 2004 4231 4233
63. M.J. Lusch, and J.A. Tallarico Demonstration of the feasibility of a direct solid-phase split-pool Biginelli synthesis of 3,4-dihydropyrimidinones Org Lett 6 2004 3237 3240
64. K.S. Atwal, G.C. Rovnyak, B.C. O'Reilly, and J. Schwartz Substituted 1,4-dihydropyrimidines. 3. Synthesis of selectively functionalized 2-hetero-1,4-dihydropyrimidines J Org Chem 54 1989 5898 5907
65. P. Wipf, C.R.J. Stephenson, and K. Okumura Transition-metal-mediated cascade reactions: C,C-dicyclopropylmethylamines by way of double C,C-σ-bond insertion into bicyclobutanes J Am Chem Soc 125 2003 14694 14695
66. P. Wipf, Stephenson CRJ, and M.A.A. Walczak Diversity-oriented synthesis of azaspirocycles Org Lett 6 2004 3009 3012
67. S.B. Moilanen, and D.S. Tan Enantioselective synthesis of erythro-4-deoxyglycals as scaffolds for target- and diversity-oriented synthesis: new insights into glycal reactivity Org Biomol Chem 3 2005 798 803
68. Reayi A, Arya P: Natural-product-like chemical space: search for chemical dissectors of macromolecular interactions. Curr Opin Chem Biol 2005, 9:in press.
69. J.S. Potuzak, and D.S. Tan Synthesis of C1-alkyl- and acylglycals from glycals using a B-alkyl Suzuki-Miyaura cross coupling approach Tet Lett 45 2004 1797 1801
70. V. Nesterenko, J.T. Byers, and P.J. Hergenrother The use of pH to influence regio- and chemoselectivity in the asymmetric aminohydroxylation of styrenes Org Lett 5 2003 281 284
71. D.F. Veber, S.R. Johnson, H-Y. Cheng, B.R. Smith, K.W. Ward, and K.D. Kopple Molecular properties that influence the oral bioavailability of drug candidates J Med Chem 45 2002 2615 2623 A recent analysis indicating that the number of rotatable bonds and polar surface area are better predictors of oral bioavailability than molecular weight and lipophilicity (C log P) and that oral bioavailability correlates partially with membrane permeability.
72. F.J. Cohen Opinion: Macro trends in pharmaceutical innovation Nat Rev Drug Discov 4 2005 78 84
73. C.P. Austin, L.S. Brady, T.R. Insel, and F.S. Collins Policy forum: molecular biology: NIH molecular libraries initiative Science 306 2004 1138 1139 An overview of the NIH screening initiative, aimed at identifying new chemical probes to support basic research and the early stages of the drug discovery process.
74. F. Kang, J. Kodah, Q. Guan, X. Li, and W.V. Murray Efficient conversion of Biginelli 3,4-dihydropyrimidin-2(1H)-one to pyrimidines via PyBroP-mediated coupling J Org Chem 70 2005 1957 1960